KATP Channel Inhibitors Reduce Cell Proliferation Through Upregulation of H3K27ac in Diffuse Intrinsic Pontine Glioma: A Functional Expression Investigation
Cancers · 22.01.2025 · 17 (3) · 358
DOI: 10.3390/cancers17030358 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancers, online erschienen am 22.01.2025. Verfasst von Marina Antonacci und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy-Pharmaceutical Sciences, University of Bari "Aldo Moro", 70125 Bari, Italy. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fondazione GAIA (Marche), Heal Foundation (Lazio), Onlus Mia Neri Foundation (Lazio).
Abstract (Originalsprache)
Background
Diffuse intrinsic pontine glioma [DIPG] is a fatal pediatric disease characterized by a post-translational modification, a replacement of lysine by methionine in position 27 of the N-terminal [H3K27M] tail of histone 3 isoform-1 [H3.1] or histone 3 isoform-3 [H3.3], respectively, expressed in the DIPG-36 and DIPG-50 cells. We investigated the role of cation channels in DIPG cells for the first time and the effects of ATP-sensitive K+[KATP] and TRPV1 channel modulators.
Methods
Experiments were performed using “in vitro” cytotoxic assays combined with the patch clamp technique, RT-PCR, Western blot, and flow cytometry assays.
Results
The most effective anti-proliferative drugs were repaglinide and glibenclamide after short and long-term incubation [6–96 h]. These drugs reduced macroscopic currents of the DIPG cells recorded in whole-cell patch clamp. Repaglinide concentration dependently enhanced the target protein H3K27ac in Western blotting after 48 h of incubation. This drug reduced cell diameter and enhanced cleaved caspase-3 in DIPG cells; total AKT/mTOR levels and phospho-mTOR were downregulated in DIPG-36.
Conclusions
KATP and TRPV1 channels are functionally expressed, and sulphonylureas are effective antiproliferative upregulating H3K27ac with apoptosis in DIPG cells and the sub-micromolar concentrations in DIPG-50.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmacy-Pharmaceutical Sciences, University of Bari "Aldo Moro", 70125 Bari, Italy.
- Functional Gastrointestinal Disorders Research Group, National Institute of Gastroenterology Saverio de Bellis, I.R.C.C.S. Research Hospital, 70013 Castellana Grotte, Italy.
ORCID-Profile: Annamaria Di Turi, Morena Miciaccia, Maria Grazia Perrone, Antonio Scilimati, Domenico Tricarico
Förderung
- Fondazione GAIA (Marche)
- Heal Foundation (Lazio)
- Onlus Mia Neri Foundation (Lazio)
- Matibellula Foundation (Piemonte)
Zitieren
APA
Antonacci, M., Maqoud, F., Di Turi, A., Miciaccia, M., Perrone, M. G., Scilimati, A., & Tricarico, D. (2025). KATP Channel Inhibitors Reduce Cell Proliferation Through Upregulation of H3K27ac in Diffuse Intrinsic Pontine Glioma: A Functional Expression Investigation. Cancers, 17(3), 358. https://doi.org/10.3390/cancers17030358
Vancouver
Antonacci M, Maqoud F, Di Turi A, Miciaccia M, Perrone MG, Scilimati A, et al. KATP Channel Inhibitors Reduce Cell Proliferation Through Upregulation of H3K27ac in Diffuse Intrinsic Pontine Glioma: A Functional Expression Investigation. Cancers. 2025;17(3):358. doi:10.3390/cancers17030358
BibTeX
@article{Antonacci2025,
author = {Antonacci, Marina and Maqoud, Fatima and Di Turi, Annamaria and Miciaccia, Morena and Perrone, Maria Grazia and Scilimati, Antonio and Tricarico, Domenico},
title = {KATP Channel Inhibitors Reduce Cell Proliferation Through Upregulation of H3K27ac in Diffuse Intrinsic Pontine Glioma: A Functional Expression Investigation},
journal = {Cancers},
year = {2025},
volume = {17},
number = {3},
pages = {358},
doi = {10.3390/cancers17030358}
}
EUVIMED